Winslow Evans & Crocker’s Bausch Health BHC Stock Holding History

Winslow Evans & Crocker’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$83K	Buy	4,000 +2,500	+167%	+$46.6K	0.02%	479
2020 Q3	$23K	Hold	1,500	–	–	0.01%	594
2020 Q2	$27K	Buy	+1,500	New	+$26.4K	0.01%	557
2019 Q2	–	Sell	-3,300	Closed	-$82K	–	1158
2019 Q1	$82K	Buy	3,300 +1,000	+43%	+$23.9K	0.02%	412
2018 Q4	$44K	Hold	2,300	–	–	0.01%	471
2018 Q3	$60K	Hold	2,300	–	–	0.02%	449
2018 Q2	$54K	Sell	2,300 -1,500	-39%	-$31K	0.02%	476
2018 Q1	$60.5K	Sell	3,800 -200	-5%	-$3.72K	0.02%	445
2017 Q4	$83.1K	Hold	4,000	–	–	0.03%	398
2017 Q3	$57.3K	Hold	4,000	–	–	0.02%	448
2017 Q2	$69.2K	Buy	4,000 +500	+14%	+$5.99K	0.02%	491
2017 Q1	$38.6K	Buy	3,500 +1,500	+75%	+$20.6K	0.01%	590
2016 Q4	$29K	Hold	2,000	–	–	0.01%	658
2016 Q3	$49.1K	Buy	+2,000	New	+$51.8K	0.01%	544
2016 Q1	–	Sell	-76	Closed	-$7.62K	–	1296
2015 Q4	$7.62K	Buy	+76	New	+$8.54K	﹤0.01%	970

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Winslow Evans & Crocker's BHC Position: Q4 2020 in Review

Winslow Evans & Crocker increased its Bausch Health (BHC) stake by 167% in Q4 2020, buying an estimated $46.6K and bringing the position to 4,000 shares worth $83K. The position accounts for 0.02% of the portfolio, ranked #479.

Winslow Evans & Crocker first reported a position in BHC in Q4 2015 and has held it in 15 quarters since. The position peaked at $83.1K in Q4 2017. 338 funds tracked by Wall St. Rank hold BHC as of Q4 2020.

Winslow Evans & Crocker held 4,000 shares of Bausch Health worth $83K as of Q4 2020.
Winslow Evans & Crocker bought 2,500 Bausch Health shares in Q4 2020, an estimated $46.6K.
Bausch Health made up 0.02% of Winslow Evans & Crocker's portfolio in Q4 2020, its #479 holding.
Winslow Evans & Crocker first reported a position in Bausch Health in Q4 2015 and has held it in 15 quarters since.
Winslow Evans & Crocker's Bausch Health position peaked at $83.1K in Q4 2017.
338 funds tracked by Wall St. Rank held Bausch Health as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.